SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Amos, R.J.
Right arrow Articles by Hinds, C.J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Amos, R.J.
Right arrow Articles by Hinds, C.J.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bone Marrow Hypoplasia During Intensive Care: Bone Marrow Culture Studies Implicating Ranitidine in the Suppression of Haemopoiesis

R.J. Amos

Department of Haematology, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

B. Kirk

Department of Haematology, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

J.A.L. Amess

Department of Haematology, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

A.L. Jones

Department of Haematology, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

C.J. Hinds

Department of Intensive Care, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, UK

Two seriously ill patients with renal failure developed bone marrow hypoplasia and peripheral blood cytopenias during admission to an Intensive Care Unit (ICU). Both patients were being treated with ranitidine and, in both, there was evidence of drug accumulation. Serum from the patient with the highest concentration of ranitidine inhibited granulocyte-macrophage colony growth from normal bone marrow. The addition of ranitidine to cultures of normal bone marrow also produced a concentration-dependent inhibition of colony growth. Ranitidine should be used with caution in patients with renal failure where drug accumulation may seriously impair bone marrow function.

Human & Experimental Toxicology, Vol. 6, No. 6, 503-506 (1987)
DOI: 10.1177/096032718700600609
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement